Skip to content

Detection of expression levels of cGAS and STING in tears of dry eye patients and normal people

Detection of expression levels of cGAS and STING in tears of dry eye patients and normal people

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200064015
Enrollment
Unknown
Registered
2022-09-23
Start date
2022-10-01
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye

Interventions

Normal group:Nil
Dry eye group: Nil

Sponsors

Eye Institute of Xiamen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Fully understand the study and voluntarily sign the ICF; willing to follow and able to complete all trial procedures. 2) 18 years old 10s seconds, Schirmer I test greater than 10mm/5min

Exclusion criteria

Exclusion criteria: 1) Patients with keratitis, conjunctivitis, severe blepharitis and other serious ocular surface diseases that affect the evaluation of efficacy; 2) Patients with acute eye diseases such as macular degeneration, glaucoma, and retinal vascular embolism; 3) Patients with lacrimal duct obstruction, obvious proptosis, and severe corneal decompensation; 4) Patients with severe dry eye or fluorescein stained punctate staining, combined with filamentous matter and ulcer; 5) Those who have had eye surgery or eye trauma within the past 6 months; 6) Those who are using other topical or systemic drugs except artificial tears, and those who use artificial tears 2 hours before the examination; 7) Patients with serious primary diseases such as cardiovascular, liver, kidney and hematopoietic system and systemic immune diseases; 8) Pregnant, lactating women, menopausal women on hormone replacement therapy; 9) Those who have participated in other clinical trials within the past 1 month; 10) Have a history of alcohol and drug abuse; 11) Patients who cannot cooperate or who are mentally ill, and the researchers believe that they are not suitable to participate in this clinical trial. 12) Exit the experiment

Design outcomes

Primary

MeasureTime frame
TBUT;Corneal staining scores;Schirmer I test;cGAS protein levels;STING protein levels;

Countries

China

Contacts

Public ContactZuguo,Liu
zuguoliu@xmu.edu.cn+86 18959289999

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026